UK Markets close in 2 hrs 35 mins
  • FTSE 100

    7,508.72
    +20.57 (+0.27%)
     
  • FTSE 250

    20,102.40
    +190.00 (+0.95%)
     
  • AIM

    914.37
    -0.38 (-0.04%)
     
  • GBP/EUR

    1.1836
    +0.0017 (+0.14%)
     
  • GBP/USD

    1.2230
    +0.0153 (+1.27%)
     
  • BTC-GBP

    19,541.85
    +443.49 (+2.32%)
     
  • CMC Crypto 200

    558.63
    +1.28 (+0.23%)
     
  • S&P 500

    4,122.47
    -17.59 (-0.42%)
     
  • DOW

    32,774.41
    -58.13 (-0.18%)
     
  • CRUDE OIL

    90.83
    +0.33 (+0.36%)
     
  • GOLD FUTURES

    1,821.70
    +9.40 (+0.52%)
     
  • NIKKEI 225

    27,819.33
    -180.63 (-0.65%)
     
  • HANG SENG

    19,610.84
    -392.60 (-1.96%)
     
  • DAX

    13,664.47
    +129.50 (+0.96%)
     
  • CAC 40

    6,537.01
    +47.01 (+0.72%)
     

Will investors benefit from quality and momentum at Biomerieux SA?

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The Biomerieux SA (EPA:BIM) share price is currently trading at €104.5. But to predict what the price will look like in the next 12 months and beyond, it's worth knowing about its strengths and potential weaknesses. The encouraging news for shareholders is that it potentially stacks up well against some important financial and technical measures...

Biomerieux SA is a large-cap share with exposure to two drivers of investment returns in the stock market: high quality and strong momentum.

Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And research suggests that positive trends in price and earnings can often persist.

To understand why quality and momentum are so important in a share like Biomerieux SA, here's a close-up view:

GET MORE DATA-DRIVEN INSIGHTS INTO EPA:BIM »

Why quality matters...

When it comes to stock analysis, company quality tends to be revealed in high profitability and strong industry-leading margins. These kinds of firms are stable, growing and often have accelerating sales and earnings. They also have strong and improving financial histories with no obvious signs of accountancy or bankruptcy risk.

One of the quality metrics for Biomerieux SA is its 5-year Return on Capital Employed, which is 16.1%. Long-term, double-digit ROCEs can be a hallmark of companies with the power to grow very profitably.

...and why momentum is so powerful

Positive momentum trends show up in share prices and earnings growth. You can find the clues in stocks that are trading close to their 52 week high prices and outperforming the market. They’ll often be beating broker estimates and getting forecast upgrades and recommendation changes.

There are signs of this at Biomerieux SA, where the share price has seen a 21.0% return relative to the market over the past 12 months. Market volatility and economic uncertainty can be a major drag on momentum, but previously strong stocks can be quick to recover when confidence returns.

In summary, a combination of high quality and momentum can be clues in the search for shares with the potential to deliver solid investment profits over many years.

In good times, these shares can become expensive to buy. But in volatile markets, there may be chances to buy them at cheaper prices.

Intrigued?

You should be. The screen that has helped unearth the stock idea detailed in this article is just one of the many tools available at Stockopedia that can help make you a better investor.

Powered by years of research and huge volumes of data analysis which are normally not available to private investors, we have developed the tools that will give you a better chance of beating the market.

What are you waiting for. Click here to sign up to your free trial today.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting